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ABSTRACT  Human erythrocytes contain an Mr 200,000 polypeptide  that cross-reacts specifi- 
cally with affinity-purified  antibodies to the Mr 200,000 heavy chain of human platelet myosin. 
Immunofluorescence  staining of formaldehyde-fixed  erythrocytes demonstrated that the im- 
munoreactive myosin polypeptide  is present in all cells and is localized in a punctate pattern 
throughout the cell. Between 20-40% of the immunoreactive  myosin polypeptide  remained 
associated with the membranes after hemolysis and preparation of ghosts, suggesting that it 
may be bound to the membrane cytoskeleton as well  as being present in the cytosol. The 
immunoreactive  myosin polypeptide was  purified  from the hemolysate to ~85% purity by 
DEAE-cellulose chromatography  followed by gel filtration  on Sephacryl S-400. The purified 
protein is an authentic vertebrate myosin with two globular heads at the end of a rod-like tail 
~150-nm  long, as visualized by rotary shadowing of individual  molecules, and with two light 
chains (Mr 25,000 and 19,500) in association with the Mr 200,000 heavy chain. Peptide maps 
of the Mr 200,000 heavy chains of erythrocyte  and platelet myosin were seen to be nearly 
identical, but the proteins are distinct since the platelet myosin light chains migrate differently 
on SDS gels (Mr 20,000 and 17,000). The erythrocyte  myosin formed  bipolar filaments 0.3- 
0.4-~m  long  at  physiological  salt concentrations  and  exhibited  a characteristic  pattern  of 
myosin ATPase activities with EDTA, Ca  ++, and Mg++-ATPase activities in 0.5 M KCI of 0.38, 
0.48, and <0.01/~mol/min per mg. The Mg++-ATPase activity of erythrocyte myosin in 0.06 M 
KCI (<0.01 ~tmol/min per mg) was not stimulated by the addition of rabbit muscle F-actin. The 
erythrocyte myosin was present in about 6,000 copies per cell, in a ratio of 80 actin monomers 
for every myosin molecule, which  is an amount  comparable to actin/myosin  ratios in other 
nonmuscle cells. The erythrocyte  myosin could function  together with tropomyosin  on the 
erythrocyte membrane (Fowler, V. M., and V. Bennett, 1984,  J. Biol. Chem., 259:5978-5989) 
in an actomyosin contractile apparatus responsible for ATP-dependent changes in erythrocyte 
shape. 
Underlying  the  plasma  membrane of eucaryotic cells  is  a 
cytoskeletal actin filament network that is believed to play a 
structural  role in  determining cell architecture as well as a 
dynamic role in generating membrane movements. The mo- 
lecular organization  of this  membrane cytoskeleton is best 
understood in the human erythrocyte, a  cell  with a  unique 
biconcave disk shape,  remarkable deformability properties, 
and no intracellular membranes or organelles. The available 
evidence indicates that the erythrocyte membrane cytoskele- 
ton  is  constructed  of many short  actin  filaments (~ 12-20 
monomers long) (26,  35) that are cross-linked into an anas- 
tomosing network in  the  plane of the  membrane by long, 
flexible spectrin molecules in association with an Mr ~80,000 
helper protein, band 4.1. The entire cytoskeletal ensemble is 
attached to the cytoplasmic surface of the membrane via the 
specific association of spectrin with ankyrin, an Mr ~210,000 
protein that is itself tightly bound to the cytoplasmic domain 
of band 3, the anion channel, and major integral membrane 
protein (for recent reviews, see references 5,  7).  The recent 
isolation of spectrin- and ankyrin-like proteins from none- 
rythrocyte  cells  and  tissues  and  their  localization  on  the 
plasma membrane (4,  10) encourage the view that the orga- 
nization  of the  erythrocyte  membrane  cytoskeleton  could 
indeed be representative of the plasma membrane cytoskele- 
ton of nucleated cells, at least in certain regions. However, as 
currently depicted, this model is an essentially static one and 
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nucleated cells (e.g., membrane ruffling, filopodial extension 
and retraction, and endo- and exocytosis), nor for dynamic 
ATP-dependent discocyte-echinocyte shape transformations 
of erythrocytes (22, 24, 34, 37). 
We  describe  here  the  identification  and  purification  of 
myosin from human  erythrocytes. The erythrocyte myosin 
was found to be present with respect to the erythrocyte actin 
in a ratio of about 80 actin monomers to 1 myosin molecule, 
an amount comparable to actin/myosin ratios in other non- 
muscle cells. In addition, we have recently identified a non- 
muscle from of tropomyosin on the erythrocyte membrane 
that is present in sufficient quantities to almost completely 
coat all of the short actin filaments in the membrane cyto- 
skeleton (14). This suggests that the erythrocyte myosin is not 
simply a relic from a previous developmental stage of the cell 
and supports the hypothesis that a membrane-associated ac- 
tomyosin contractile apparatus could be responsible for ATP- 
dependent changes in erythrocyte shape and deformability. 
MATERIALS  AND  METHODS 
Production and Purification of Antibodies:  Myosin was puff- 
fled from outdated  human platelets as described by Pollard et al. (28) and was 
stored  at  4"C as a  slurry  in  60%  saturated  ammonium sulfate. Three  New 
Zealand  white rabbits  were injected subcutaneously  at multiple  sites on the 
back and sides with  100-150 ,g each of native myosin in complete Freund's 
adjuvant,  followed by booster injections with antigen in incomplete  Freund's 
adjuvant  after 3 wk, and then at l-2-mo intervals thereafter, Titer was moni- 
tored  by the  immunoblot method  (see below) and was high after  the  third 
injection.  Immune serum was diluted  with  1 vol of 150 mM NaCI, 10 mM 
sodium phosphate,  1 mM EDTA,  1 mM NAN3, 0.2% (vol/vol) Triton X-100, 
heated to 60"C in the presence of 200 ,g/ml phenylmethylsulfonyl fluoride to 
minimize  protease  activity,  and  stored  at  -20"C.  Antibody  against  platelet 
myosin  was  isolated  by  affinity  chromatography  with  myosin  coupled  to 
cyanogen bromide-activated  Sepharose (CI) 4B (Pharmacia  Fine Chemicals, 
Piscataway, N  J) (0.7 mg of myosin/ml ofagarose).  10-20 ml of  immune serum 
was applied to a 3.5-ml column, the column was washed, and antibody  was 
eluted as described previously (14). Peak fractions (based on A2ao) were pooled, 
concentrated three- to fourfold by dialysis into  150 mM NaCI, 10 mM sodium 
phosphate,  I mM Na EDTA, 0.02% NAN3, pH 7.5, 50% glycerol at 4"C, and 
stored  at -20"C.  Yields of purified  antibody  ranged  from 0.03 to 0.10  mg 
(based on E~0 =  14) per milliliter of diluted serum, depending on the rabbit. 
Although the antibodies were isolated by affinity chromatography  with native 
platelet myosin, they were specific for the heavy chain and did not label the 
light chains in immunoblotting assays. Ig was isolated from preimmune serum 
by  affinity  chromatography  on  Protein  A-Sepharose (14), Affinity-purified 
antibodies to human erythrocyte spectrin were a gift from Dr. Peter C. Agre 
(Department  of Medicine, The Johns Hopkins University School of Medicine). 
Preparation of Hemolysate, Membranes, and Purified Pro- 
teins:  Erythroeytes were isolated from freshly drawn human blood antico- 
agulated with acid/citrate/dextrose  as described (6). Cells were lysed in  10-15 
vol of ice-cold 7.5 mM sodium phosphate,  1 mM EDTA, 2 mM dithiothreitol 
(DTT)? 20 #g/ml of phenylmethylsulfonyl  fluoride, pH 7.5, and the  mem- 
branes  were pelleted  by  centrifugation  as  described  (6); this  supernatant  is 
referred to as the hemolysate. Membranes were prepared by three more washes 
in the lysis buffer (6). Ankyrin and spectrin were purified from membranes as 
described (6), and the M, 200,000 immunoreactive  myosin polypeptide from 
the  hemolysate  as described  in  the  text  and  the  legend to  Fig.  3.  Protein 
concentrations  for the purified proteins  were determined  spectrophotometri- 
cally from the absorbance at 280 nm (after correction for light scattering at 320 
nm) based on an E]~ value of 10 for spectrin and ankyffn, and 5.9 for myosin 
(28). 
Electrophoresis  and  Immunoblotting  Procedures:  Elec- 
trophoresis was performed  on 5-15%  acrylamide linear gradient  SDS gels in 
the presence of 4 M urea, with a 5%  stacking gel containing  2 M urea, and 
with sample preparation and molecular weight standards as described previously 
(14). Electrophoretic transfer ofpolypeptides from the SDS gels to nitrocellulose 
paper was performed as described previously (14) except that gels were trans- 
Abbreviation  used in this paper: DTT, dithiothreitol. 
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ferred for 6 h at 500-700  mA current at 15°C. Nitrocellulose gel transfers were 
labeled overnight (12-18 h) at 4"C with 2-4 #g/ml of  aflqnity-purified  antibodies 
to human platelet  myosin,  and  processed for  antibody  detection  with  ]25I- 
Protein A (2 ×  l06 cpm/ml) as described (14). 
We quantitated  the  amount of the  Mr 200,000  immunoreactive  myosin 
polypeptide in a sample by staining the protein on the nitrocellulose transfers 
with 0.2% ponceau S in 3% trichloroacetie acid (10 rain at room temperature 
followed by two washes in distilled water), cutting out the appropriate  region 
of  the nitrocellulose, and counting the ~2~l-Protein A-labeled band in the gamma 
counter.  The actual  micrograms  of the  immunoreactive  myosin polypeptide 
were computed from a standard  curve prepared from immunoblots of known 
amounts of purified erythrocyte myosin that were electrophoresed on SDS gels 
and transferred to nitrocellulose in parallel with the unknowns. The standard 
curve was linear from ~0.02 to at least 0.25 ,g of  protein, and duplicate samples 
were reproducible _+ 5%. The concentration  of the purified erythrocyte myosin 
for the standard  curve was based on the A2so, assuming E2s0~ =  5.9 (28), and 
corrected for the purity of the preparation  (~85%; see Results) by multiplying 
by a factor of 1.2. 
Immunofluorescence of Erythrocytes:  Erythrocytes (isolated as 
described  above)  were  fixed in  suspension  (10% [vol/vol])  in  3%  (wt/vol) 
paraformaldehyde in PBS (150 mM NaCI, 10 mM sodium phosphate, pH 7.5) 
for 15 rain at room temperature,  and then allowed to settle onto poly-t-lysine- 
coated  coverslips  (No.  2)  for an  additional  5  min  at  room  temperature. 
Coverslips were washed three times in PBS, incubated 30 rain at room temper- 
ature in 50 mM NH,CI in PBS, and then washed three times in PBS. Cells on 
coverslips  were  permeabilized  by  a  30-s incubation  in  acetone  at  -20"C, 
transferred  immediately  to  PBS containing  0.2% gelatin  (PBS/gelatin), and 
then washed two times in PBS/gelatin. Coverslips were placed over 50-#1 drops 
of affinity-purified antibodies or preimmune Ig (10 #g/ml in PBS/gelatin) and 
incubated  for 30 min at room temperature  in a humid chamber.  After four 
washes in PBS/gelatin they were incubated  for 20 min at room temperature 
with tetramethyl  rhodamine  isothiocyanate goat anti-rabbit  IgG (Miles Labo- 
ratoffes, Elkhart, IN) (1/400 dilution in PBS/gelatin). Following two washes in 
PBS/gelatin and two washes in PBS, coverslips were mounted on slides in 50% 
glycerol, 50% PBS and examined in a Zeiss microscope equipped with epiflu- 
oreseence optics. Micrographs were taken  with Kodak  Tri-X  pan film, ASA 
800. 
Antimyosin staining of erythrocytes was only obtained  with the formalde- 
hyde fixation, acetone postfixation/permeabilization  protocol described above. 
Formaldehyde fixation followed by permeabilization  with 0.1% Triton  X- 100 
resulted in extraction of the phase-dense cytoplasmic contents of the cells and 
completely eliminated  the antimyosin  staining. Also, no specific staining was 
visible with acetone treatment  alone in the absence of formaldehyde fixation. 
The antispectrin staining was identical regardless of the fixation/permeabiliza- 
tion protocol. 
Electron  Microscopy:  For rotary  shadowing,  purified  erythrocyte 
myosin in 0.5 M KC1 was dialyzed at a concentration  of 30 #g/ml against 100 
mM ammonium formate, 30% (vol/vol) glycerol, pH 7.0, sprayed onto freshly 
cleaved mica, dried under vacuum at room temperature,  and rotary shadowed 
at an  angle of 1-10" with  platinum followed by carbon  (36). For negative 
staining, purified myosin in 0.5 M KCI was dialyzed at a concentration  of 200 
ug/ml against 50 mM KCI, 2 mM MgC12, 10 mM PIPES, pH 7.0, 4"C, to form 
filaments. After dilution and application to Formvar- and carbon-coated grids. 
the myosin was negatively stained with  t% uranyl acetate. Rotary  shadowed 
and  negatively stained  samples were photographed  using a Zeiss microscope 
operating at 80 kV. 
RESULTS 
Identification  of Myosin  in Human Erythrocytes 
Previous attempts to identify myosin in  human  erythro- 
cytes have  been  frustrated  by  the  similarity in  molecular 
weight of the myosin heavy chain (Mr 200,000) to the major 
membrane-associated cytoskeletal proteins  spectrin  (M,  of 
band 2 ~220,000) and ankyrin (Mr ~210,000), and by high 
levels of ATP hydrolysis resulting from membrane-associated 
ion  pumps  and  coupled  kinase-phosphatase  activities  in 
whole-cell lysates,  membranes, and membrane extracts. To 
circumvent these problems, we prepared antibodies to platelet 
myosin to use as a specific probe in assaying for the presence 
of myosin in erythrocytes. Fig.  1 shows that affinity-purified 
antibodies to the M, 200,000 heavy chain of human platelet 
myosin  cross-reacted  with  an  Mr  200,000  polypeptide  in FIGURE  I  Identification of an M, 200,000  immunoreactive myosin polypeptide in human erythrocytes. (Lane  I)  Erythrocytes; 
(lane 2) cytosol; (lane 3) membranes;  (lane 4) erythrocyte ankyrin (1.5 #g); (lane 5) erythrocyte spectrin (2 #g); (lane 6) platelet 
myosin. (Panel A,  1.6 #g; panel B, 0.08/~g).  Erythrocytes  were lysed in 15 vol of lysis buffer and membranes  were prepared  as 
described in Materials and Methods. Aliquots of the lysed erythrocytes, the hemolysate  (cytosol),  and the washed membranes 
resuspended to the initial lysis volume were added directly to SDS gel electrophoresis sample buffer (14) and heated to 80°C for 
5 min. 80-/A samples of each were electrophoresed on 5-15% acrylamide linear gradient SDS gels in the presence of 4 M  urea, 
and either (A) stained with Coomassie  Blue or (B) electrophoretically transferred  to nitrocellulose paper as described in Materials 
and Methods. The nitrocellulose strips were incubated with 2 #g/ml of affinity-purified antibodies to human platelet myosin, or 
preimmune  Ig, followed  by incubation with 12Sl-labeled protein A.  Immunoreactive bands were detected  by autoradiography 
after exposure of the film for I  h. 
human erythrocytes. Preimmune Ig did  not label either the 
purified platelet myosin (Fig.  1, lane 6) or the cross-reactive 
polypeptide in the erythrocytes (Fig.  1, lanes 1-3).  The im- 
munoreactive  polypeptide  was  not  band  2  of spectrin  or 
ankyrin (Mr equivalent to band 2  of spectrin on these gels), 
since  neither  purified ankyrin (Fig.  1,  lane  4)  nor purified 
spectrin  (Fig.  1,  lane  5)  were  labeled  by  the  antimyosin 
antibodies. These results suggest that the immunoreactive Mr 
200,000 polypeptide could be the M, 200,000 heavy chain of 
an erythrocyte myosin-homologue. 
To determine whether this immunoreactive myosin poly- 
peptide was localized on the membrane or in the cytosol, we 
lysed erythrocytes and compared immunoblots of whole cells, 
hemolysates,  and  membranes  (Fig.  1,  lanes  1-3).  A  true 
cytoplasmic component would be expected to be present in 
the hemolysate in the same proportion as in the whole cells, 
whereas  a  tightly  bound  membrane component  would  be 
expected to be associated exclusively with the washed mem- 
branes. Fig.  1 shows that only ~30-40% of the immunoreac- 
tive myosin  polypeptide was released  into  the  supernatant 
during hemolysis of erythrocytes in  7.5  mM sodium phos- 
phate, pH 7.5  (Fig.  1, lane 2),  while an additional 30-40% 
was washed  off the  membranes during  the  preparation  of 
ghosts (Fig.  1,  lane 3).  2 This intermediate fractionation be- 
havior might be expected from a  component that is loosely 
bound to the membrane as well as being present in the cytosol. 
However, a variable proportion of the putative myosin hom- 
ologue may also be tightly associated with the  membranes 
since ~20-30%  of the immunoreactive myosin polypeptide 
remained  associated  with  the  membranes  even  in  well- 
washed, white ghosts (Fig.  1, lane 3), and inclusion of phys- 
iological concentrations of magnesium (2  mM) in  the  lysis 
and washing buffers resulted in about a  twofold increase in 
this amount (data not shown). 
Immunofluorescence staining of formaldehyde-fixed eryth- 
rocytes with the affinity-purified antibodies to myosin dem- 
onstrated that the immunoreactive myosin polypeptide was 
present in all cells (Fig. 2 a). The putative erythrocyte myosin- 
homologue was thus not derived from reticulocytes or from 
contaminating platelets or neutrophils in the cell preparations. 
No  staining  with  preimmune Ig was observed under these 
conditions (Fig.  2c).  The antimyosin staining was only ob- 
served when the fixed cells were permeabilized with acetone 
2  Estimated by quantitative immunoblotting procedures as described 
in Materials and Methods. 
FOWLER  ET  AL.  Human Erythrocyte Myosin  49 FIGURE  2  Immunofluorescence staining of human erythrocytes with antiplatelet myosin (a), preimmune Ig (c), and antispectrin 
(e). b, d, and f are phase-contrast micrographs corresponding to a, c, and e. Erythrocytes were fixed with 3% paraformaldehyde 
followed by acetone at -20°C and incubated with the various rabbit Ig samples at 10 pg/ml, followed by rhodamine-conjugated 
goat anti-rabbit IgG, as described in Materials and Methods. The antispectrin staining in e is actually 50-100-fold  brighter than 
the antimyosin staining in a (estimated by the exposure times used to photograph the cells and to print the negatives), but the 
micrographs are printed so as to be on the same scale for comparison. (a-f)  Bar,  10 pm. x  9,000. (Inset) x  18,000. 
before incubation with the antibody, indicating that the im- 
munoreactive myosin polypeptide was in the interior of the 
cell and not adsorbed adventitiously to the cell surface. The 
antimyosin staining was variable in intensity and was distrib- 
uted in a granular or punctate pattern in each cell (Fig. 2a, 
see inset).  The small size of the cells and the relatively dim 
staining made it difficult to determine whether the punctate 
antimyosin staining was localized in the cytosol and/or asso- 
ciated with the membrane in the fixed cells. The punctate 
staining pattern was probably not artifactuaUy induced by the 
fixation/permeabilization protocol because staining with af- 
finity-purified  antibodies to spectrin produced a uniform rim- 
staining pattern (Fig. 2 e), which is consistent with the estab- 
lished location of spectrin on the cytoplasmic surface of the 
membrane (5, 23, 39). 
Purification and Partial Characterization of 
Erythrocyte Myosin 
To evaluate the possibility that the immunoreactive myosin 
polypeptide is the Mr 200,000 heavy chain of an erythrocyte 
myosin-homologue, we  purified the  polypeptide from  the 
hemolysate and compared its physical and functional prop- 
erties with those established for authentic vertebrate myosins 
(19,  21,  29).  The immunoreactive myosin polypeptide was 
separated from the enormous amount of hemoglobin, as well 
as numerous other cytosolic proteins in the hemolysate, by 
DEAE-cellulose chromatography in the presence of 20 mM 
sodium pyrophosphate, pH 7.5 (Fig. 3A, compare lanes I and 
2). This procedure also served to concentrate the Mr 200,000 
immunoreactive myosin polypeptide by about 25-fold with 
respect to its original concentration in the hemolysate (<1 
gg/ml).  2 The Mr 200,000 polypeptide was then concentrated 
an additional 10-fold by precipitation with ammonium sulfate 
at 60% saturation (Fig. 3A, lane 3) and separated from most 
of the low molecular weight polypeptides by gel filtration in 
0.5 M KC1 on Sephacryl S-400 (Fig. 3A, lane 4). When more 
protein was  loaded on the gels,  two low molecular weight 
polypeptides (Mr 25,000 and  19,500) were seen to be associ- 
ated with the purified Mr 200,000 polypeptide (Fig. 3 B, lane 
1). These polypeptides were present in a molar ratio of 1.09 
Mr 25,000:0.90 Mr  19,500:1.0  Mr 200,000 polypeptide,  3 and 
thus presumably represent the two light chains that would be 
expected to be associated with the Mr 200,000 heavy chain of 
an erythrocyte myosin molecule. Together, these three poly- 
peptides accounted for ~85% of the Coomassie Blue-staining 
material  in  the  purified preparation.  In  the  representative 
experiment shown in Fig. 3, -0.7 mg of protein was obtained 
from two units of  blood, which represents a recovery of- 18% 
of the  protein present  as the Mr  200,000  immunoreactive 
myosin polypeptide in the hemolysate.  2 
Structurally, the purified erythrocyte myosin is a  typical 
vertebrate myosin, with two heads and a  long rod-like tail 
~ 150 nm long (21, 29, 36), as visualized by low angle rotary 
shadowing of individual molecules (Fig. 4, left column). The 
double-headed appearance of the individual molecules, to- 
gether with the roughly equimolar stoichiometry of the Mr 
200,000,  25,000,  and  19,500  polypeptides (1:1.09:0.90,  see 
above), suggests that the native molecules are dimers of two 
heavy chains,  each with two associated light chains,  as are 
other myosins. In addition, peptide maps of the Mr 200,000 
3 Determined by  quantitative elution  of dye  from  the Coomassie 
Blue-stained protein bands as described by Fenner el al. (12). 
50  THE JOURNAL OF CELL BIOLOGY • VOLUME 100, 1985 FIGURE 3  (A) Purification of human erythrocyte myosin.  Erythrocytes were isolated from two units of whole blood as described 
by Bennett (6) and lysed in 12 vol of ice-cold 7.5 mM sodium phosphate,  I  mM EDTA, 2 mM DTT, 20/~g/ml phenylmethylsulfonyl 
fluoride (pH 7.5), and the membranes were removed by centrifugation for 45 min at 17,000 g (2°C). The hemolysate (3,300 ml) 
was adsorbed batchwise  to DEAE-cellulose equilibrated with 20 mM sodium pyrophosphate, I  mM EDTA, 2 mM DTT (pH  7.5) 
for I  h at 4°C with stirring, and unadsorbed protein (mainly hemoglobin) was removed by several cycles of settling and decanting 
of the DEAE in this buffer.  The DEAE was poured into a column (2.5 x  18 cm), washed with 5 column volumes of 50 mM NaCl, 
20 mM sodium pyrophosphate, I  mM EDTA, 2 mM DTT (pH 7.5), and then eluted with 7 column volumes of a 50-250 mM NaCI 
linear gradient in  the same buffer,  collecting 10-ml  fractions.  Fractions containing the  immunoreactive myosin  polypeptide 
(assayed by immunoblotting procedures) were pooled (150 ml), and the protein was precipitated by addition of 1.5 vol of ice- 
cold, saturated ammonium sulfate and then collected by centrifugation for 20 min at 17,000 g. The precipitate was resuspended 
to a 13-mi final vol in 0.5 M  KCI, 10 mM Tris, I  mM EDTA, I  mM DTT (pH  7.5), and centrifuged for 30 rain at 100,000 g. The 
supernatant  was applied to a Sephacryl  S-400 column (2.5 x  85 cm)  equilibrated with the same buffer and run  at 20 ml/h, 
collecting 5-ml  fractions.  Fractions containing the  Mr 200,000  polypeptide eluted at  ~1.5  V0 and  were pooled (40  ml)  and 
concentrated 5-10-fold to 0.1-0.2 mg/ml by dialysis against solid sucrose. The purified protein was stored on ice after dialysis 
against 0.5 M  KCl, 10 mM 3-(N-morpholino) propane sulfonic acid, I  mM EDTA, I  mM DTT (pH 7.0) and was stable for at least 
3 wk. Samples of hemolysate (80 #I) [lane I ], the DEAE pool (40/~I) [lane 2], the ammonium sulfate-concentrated  material (20 #I) 
[lane 3], and the purified Mr 200,000 polypeptide (2/~g) [lane 4] were electrophoresed on 5-I 5% acrylamide linear gradient SDS 
gels containing 4 M  urea and either stained with Coomassie Blue (left)  or transferred to nitrocellulose and labeled with 4/Lg/ml 
platelet myosin and 1251-1abeled  protein A (right)  as described in Materials and Methods. One tenth as much  protein was loaded 
for the immunoblots, and the immunoreactive bands were detected after exposure of the autoradiograms for only 30 min. Lane 
5 is 2/~g of purified human platelet myosin for comparison.  (B) Comparison of 6 #g each of purified human erythrocyte myosin 
(lane  I) and human platelet myosin  (lane 2) on 7.5-15% acrylamide linear gradient SDS gels in the absence of urea (14). HC, 
heavy chains; (LC), light chains. 
heavy chain of the purified erythrocyte myosin and of platelet 
myosin were found to be nearly identical (Fig.  5), indicating 
a  high degree  of structural homology between the two pro- 
teins. However, these proteins are distinct in that the molec- 
ular weights determined for the platelet myosin light chains 
on 7.5-15 % acrylamide linear gradient SDS gels (Mr 20,000 
and 17,000; Fig.  3 B, lane 2) were different  from those deter- 
mined for the erythrocyte myosin light chains (Mr 25,000 and 
19,500; Fig.  3B, lane 1). 
Dialysis of the purified erythrocyte myosin into low salt led 
to formation of typical bipolar myosin filaments (0.3-0.4 pm 
long) with the heads at each end and a central bare zone in 
the middle (Fig.  4, middle and right column). Occasionally, 
possible  intermediate  stages  in  the  formation  of these  fila- 
ments were observed in the rotary-shadowed specimens. For 
example,  two molecules are  associated  via their tails in the 
bottom left panel of Fig. 4, and the head end of an individual 
myosin  molecule  is  splayed  out  from  the  bipolar filament 
while  the tail  region  remains  attached in  the  filaments  de- 
picted in the bottom two panels of the middle column in Fig. 
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shadowed specimens as compared with the negatively stained 
specimens may  be  due  to  the  somewhat  different  dialysis 
conditions used for the sample preparations (0.1  M  ammo- 
nium formate, pH 7.5, versus 50 mM KC1, 2 mM MgC12, pH 
7.0), or it may be an artifact of the respective electron micro- 
scopic techniques. 
The purified erythrocyte myosin exhibited a characteristic 
pattern of myosin ATPase activities, with a  Ca++-activated, 
Mg+÷-inhibited  ATPase activity at both  high  and  low  salt, 
and activation by high concentrations of KC1 but not NaC1 
in the absence of divalent cations (2  mM EDTA) (Table I). 
The Ca+2-ATPase  activity in  0.5  M  KC1 of the  erythrocyte 
myosin was higher than the EDTA-ATPase activity measured 
in 0.5 M KC! (0.48  and 0.38 ~mol/min per mg, respectively). 
This is the  reverse of the  relative Ca  +÷ and  EDTA-ATPase 
activities of platelet  myosin measured  under similar condi- 
FIGURE 4  Electron  micrographs  of  low  angle,  rotary-shadowed 
individual human erthyrocyte myosin molecules (left)  and myosin 
filaments  (middle), and  of  negatively  stained  myosin  filaments 
(right). Bar, 200 nm. x  100,000. 
tions  (0.35  and  0.50  umol/min  per  mg,  respectively,  see 
reference 28).  The addition of rabbit skeletal muscle F-actin 
(I  mg/ml) to purified erythrocyte myosin had  no effect on 
the low Mg÷+-ATPase activity of erythrocyte myosin that was 
measured in 60 mM KC1, 2 mM MgC12, pH 7.0 (<0.01 umol/ 
min per mg). 
Determination of the Number of Copies of 
Myosin per Cell 
The purified erythrocyte myosin was used as a standard in 
a quantitative immunoblotting assay to determine the amount 
of myosin in erythrocytes (Materials and Methods). As shown 
in  Table II, the amount of the Mr 200,000  heavy chain of 
erythrocyte myosin detected was directly proportional to the 
microliters of cell equivalents electrophoresed and transferred 
to nitrocellulose, which demonstrates that the assay is oper- 
ating in both antimyosin antibody and  ~25I-protein A excess. 
Additionally, this also shows that the co-migrating spectrin 
(band 2)  and  ankyrin polypeptides are  not  interfering with 
the transfer or antibody labeling of the erythrocyte myosin 
heavy chain. The molar ratio of the Mr 200,000 polypeptide 
to spectrin was calculated with respect to the micrograms of 
band  1  of spectrin  in  each  sample  because  there  are  no 
polypeptides co-migrating with band  1 of spectrin on these 
SDS gels of erythrocytes. The average value for the ratio of 
spectrin to myosin calculated from the values in Table I was 
32.1  spectrin dimers/myosin molecule (dimer of two heavy 
chains). Since there are 200,000 molecules of spectrin dimer 
per cell (5), the number of molecules of myosin per cell would 
be 6,240.  This is a ratio of about 80 actin monomers for every 
myosin molecule, assuming there are 500,000 copies of actin 
per cell (5, 26). 
DISCUSSION 
The  possibility that  erythrocytes contain  myosin  has  been 
discussed since 1960 when Nakao et al. (22) first observed the 
reversible ATP-dependent discocyte-echinocyte shape trans- 
formations of human  erythrocytes.  The  ability  of isolated 
membranes (ghosts) to undergo similar ATP-dependent shape 
transformations (24,  34,  37),  as well  as ATP-dependent en- 
docytosis (25,  31), led numerous investigators to hypothesize 
FIGURE 5  Two-dimensional peptide maps of 12Sl-labeled  chymotryptic peptides of human erythrocyte myosin heavy chain (a), 
human platelet myosin heavy chain (b), and a mixture of peptides from platelet and erythrocyte myosin heavy chains (c). Myosin 
from  platelets  and erythrocytes (50  pmol each) was denatured in 0.1% (wt/vol) SDS, radiolabeled with  1 mCi  of 1251 by using 
chloramine-T as an oxidant, and electrophoresed on an SDS polyacrylamide gel. The 12Sl-labeled heavy chains were localized by 
staining with Coomassie  Blue, cut from the gel, and digested  with 50/~g/~l alpha-chymotrypsin in 50 mM ammonium formate,  1 
mM NaN3 for 18 h at 37°C. The digest was lyophilized and analyzed by electrophoresis (horizontal dimension) and chromatography 
(vertical dimension) as described (11). 
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a membrane-associated actomyosin contractile apparatus. At 
one point, it was suggested  that spectrin might be a myosin- 
like protein (15) and that the actin-spectrin network under- 
lying  the  membrane  could  be  the  erythrocyte membrane 
analogue to actomyosin contractile systems in other cells (33, 
34). However, the extensive work on the physical and func- 
tional properties of spectrin (18) and the recent identification 
of spectrin-like proteins in  nonerythrocyte cells and tissues 
(4,  5)  have  made  it  abundantly  clear that  spectrin  is  not 
myosin. In this report we have established the presence in the 
human erythrocyte of an authentic vertebrate myosin, based 
on cross-reaction with affinity-purified antibodies to human 
platelet myosin and  characterization of the  structural  and 
functional properties of the purified protein.  Myosin is an 
endogenous component of mature human erythrocytes, based 
on immunofluorescence localization of myosin in all  cells, 
and is present with respect to the actin on the erythrocyte 
membrane in an amount comparable to actin/myosin ratios 
in other nonmuscle cells (molar ratio =  80/1; see reference 
29). Our work confirms and extends a preliminary report by 
Kirkpatrick and Sweeney (17) that erythrocyte cytosol con- 
tained  myosin, and also  presumably accounts for previous 
observations of myosin-like ATPase activities in crude prep- 
arations of spectrin from erythrocyte membranes (3, 30). 
In retrospect, there are several reasons why the presence of 
myosin in the erythrocyte has been previously overlooked. 
First, the intensity of antimyosin staining of erythrocytes is 
considerably less intense than that of platelets or neutrophils 
in samples of whole blood processed for indirect immunoflu- 
orescence (V. Fowler, unpublished data). Second, the presence 
of interfering ATPase activities, and the similarity in molec- 
ular weight on SDS gels of the myosin heavy chain to the 
major cytoskeletal proteins, spectrin and ankyrin, makes it 
impossible to employ the usual criteria for initial identifica- 
tion of myosin. Finally, attention has focused on structural 
proteins that are tightly associated with the membrane, while 
the majority of the erythrocyte myosin is released into the 
supernatant during hemolysis and preparation of membranes 
under hypotonic conditions (7.5 mM sodium phosphate, pH 
7.5). 
In common with myosins isolated from various nonmuscle 
cells, the Mg++-ATPase activity of erythrocyte myosin is not 
enhanced by the addition of rabbit skeletal muscle F-actin 
(19,  29).  Actin  activation  of the  Mg++-ATPase  activity of 
platelet and  other cytoplasmic myosins, as well  as smooth 
muscle myosin, occurs only after the Mr 20,000 light chain of 
the myosin has been phosphorylated by a calcium- and cal- 
modulin-dependent protein kinase  (1).  Thus,  it is  possible 
that the Mr 19,500 light chain of erythrocyte myosin could be 
TABLE  I 
A TPase Activity of Erythrocyte Myosin 
10 mM  10 mM 
2 mM  EDTA  CaCI2  MgCI2 
0.5 M  KCI  0.376  0.478  <0.01 
0.06 M  KCI  0  0.406  <0.01 
0.5 M  NaCI  0.118  0.204  0 
ATPase activities (/amol/min  per mg) were determined by using 25 #g/ml of 
purified  erythrocyte  myosin  in  a  buffer  containing  10  mM  3-(N-morpho- 
lino)propane sulfonic acid, I  mM ATP, pH 7.0, ions as specified above, and 
0.5/aCi/ml [3,-~2P]ATP. The radioactivity released as P~ was determined after 
incubation  for  15  and  30  rain  as  described  by Agre  et  al.  (2), and  was 
corrected for nonenzymatic Pj release in the absence of myosin. 
TABLE  II 
Quantitation of the Amount of Myosin in the Erythrocyte 
Cell equivalents (#I)* 
1.0  1.5  2.0 
Spectrin band 1 (#g)*  0.66  0.99  1.32 
Erythrocyte myosin  0.030  0.048  0.066 
(#g)S heavy chain 
Spectrin dimer/myosin  33.8  31.7  30.8 
(mol/mol) H 
Molecules myosin per  5,917  6,309  6,494 
cell  ~ 
* Calculated from the microliters of sample electrophoresed for each deter- 
mination and the volume of packed cells  used  to  prepare the initial gel 
sample. 
* Determined by the dye elution method of Fenner et al. (12) from a standard 
curve constructed by electrophoresing known quantities of purified spectrin 
in parallel  with the gel samples of the erythrocytes. 
t Determined by a quantitative immunoblotting procedure as described in 
Materials  and Methods. 
| Calculated assuming M, 260,000  lot band 1 of spectrin and Mr 200,000  for 
the heavy chain of erythrocyte myosin, and that each spectrin molecule 
(dimer)  contains one band 1 polypeptide whereas each  myosin molecule 
contains two Mr 200,000  heavy chains. 
Calculated assuming 200,000  spectrin dimers per cell (5). 
homologous to the Mr 20,000 regulatory light chains of other 
cytoplasmic myosins, and as isolated, be in the dephosphor- 
ylated state.  Regulation of the level of phosphorylation of the 
M,  19,500  light chain of erythrocyte myosin by a  calcium- 
and  calmodulin-dependent protein  kinase,  coupled with  a 
myosin light chain phosphatase, could provide a mechanism 
for calcium control oferythrocyte actomyosin ATPase activ- 
ity,  as  has been  described for platelet and  smooth muscle 
actomyosin systems (1). However, the presence in erythrocyte 
myosin of a light chain of apparent Mr 25,000 on SDS gels, 
similar to vertebrate skeletal and cardiac muscle myosins (21, 
38), and unlike other previously characterized cytoplasmic or 
smooth muscle myosins (19,  29),  suggests that other regula- 
tory mechanisms  should be considered. For example, it is 
possible that actin activation of the Mg+*-ATPase activity of 
erythrocyte myosin could be specific for erythrocyte mem- 
brane actin, which consists exclusively of the beta-isoelectric 
variant (reference 27 and  V.  Fowler, unpublished data), as 
suggested by Schrier et al. (32). Calcium regulation of eryth- 
rocyte actomyosin ATPase activity could then be provided by 
an actin-linked erythrocyte troponin-tropomyosin system, as 
discussed previously (14).  Clearly, these  regulatory mecha- 
nisms are not mutually exclusive, and additional myosin or 
actin-linked  mechanisms  for  control  of erythrocyte acto- 
myosin ATPase activity might also exist (19, 29). 
Myosin in the human erythrocyte could function, together 
with  the  membrane-associated actin  protofilaments,  in  an 
actomyosin  contractile  apparatus  responsible  for  ATP-de- 
pendent discocyte-echinocyte  changes in cell shape and mem- 
brane properties (25, 31, 34, 37). Additionally, the passage of 
erythrocytes through the narrow sinusoids in the spleen may 
not be entirely a passive process driven by hydrostatic pres- 
sure, but may be facilitated by energy-dependent actomyosin 
contractions that  are triggered by increases in  intracellular 
calcium resulting from enhanced passive calcium permeabil- 
ity induced by physiological shear stresses  (20).  Such a  hy- 
pothesized actomyosin contractile apparatus is probably not 
permanently assembled on the erythrocyte membrane, since 
much of the  myosin is  released into the  supernatant after 
hemolysis of fresh, ATP-replete biconcave cells. The interac- 
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is  likely to  be complex and  regulated  at  several  levels:  the 
ATP-dependent interaction of myosin heads with the actin 
protofilaments  in  the  membrane  skeleton  (actomyosin 
ATPase);  the self-association  of molecules into bipolar fila- 
ments;  and the association of filaments or individual myosin 
molecules via their tails to a nonactin site on the membrane. 
It is tempting to speculate that the increases  in intracellular 
calcium and depletion of ATP levels that are correlated with 
discocyte-echinocyte  shape  transformations  of erythrocytes 
(22,  24,  37)  could be functionally related  to  assembly and 
activity of an actomyosin contractile  apparatus on the eryth- 
rocyte membrane. 
Although there  is no precedent  for the organization and 
functioning of a membrane-associated contractile  apparatus, 
the ability of erythrocyte myosin to form bipolar filaments at 
the concentrations of myosin estimated to be present in the 
erythrocyte (-50 pg/ml)  4 raises the possibility  that force pro- 
duction and membrane movements could result from ATP- 
dependent sliding of  bipolar myosin filaments past antiparallel 
actin  filaments  in  the  membrane  skeleton.  The  punctate 
character  of the antimyosin staining of erythrocytes  and the 
ratio of actin to myosin (80 monomers/myosin molecule; or 
1,200 monomers/1  myosin filament of 15 monomers; refer- 
ence 29) suggest that actomyosin interactions might occur at 
specialized sites  in the  membrane skeleton.  Localized con- 
tractions  could be transmitted through the cytoskeletal net- 
work via the multiple spectrin-band  4.1  linkages between the 
actin  protofilaments,  and  tension  could be  exerted  on  the 
membrane via the specific  association  of spectrin  with  an- 
kyrin.  Alternatively,  individual  myosin molecules could be 
attached  directly  to a  membrane site  via their  tails,  leaving 
their heads free to interact with the actin protofilaments. The 
relationship  of  such  hypothesized  calcium-activated  acto- 
myosin contractions of the membrane cytoskeletal network 
to the  previously observed inhibition  of spectrin-band  4.1- 
actin gelation by micromolar calcium (13) is not immediately 
apparent.  It is possible that the intracellular  free calcium ion 
concentration could regulate spectrin-band  4.1-actin interac- 
tions concurrently with actomyosin contractions in a mem- 
brane-associated  counterpart of the solation-contraction cou- 
pling mechanism that has been proposed to explain amoeboid 
movements (8, 9,  16). Clearly,  evaluation of these ideas will 
require  extensive  biochemical and  ultrastructural  investiga- 
tion  of the  interaction  of myosin with the  membrane and 
with the actin filaments in the membrane skeleton. In partic- 
ular, the relationship  of actomyosin interactions to the spec- 
trin-band  4. l-actin linkages in the membrane cytoskeleton, 
as well as the locations and associations of potential regulatory 
proteins such as tropomyosin (14) or troponins, will need to 
be defined. 
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4 Calculated from the number of copies of myosin per cell (6,000, see 
Results) and a cell volume of 85 um  3. 
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Note added in Proof.  In a recent experiment by Albert J. Wong, 
Daniel P. Kiehart, and Thomas D. Pollard (J. BioL Chem., in press), 
phosphorylation of the M,  19,500 light chain was observed to be 
correlated with the actin-activated ATPase activity of erythrocyte 
myosin. 
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